Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference

NEXT STORY
Shockwave Intravascular Lithotripsy FDA Approved to Treat Advanced Heart Disease
PREV STORY
Worldwide Molecular Biology Enzymes, Reagents and Kits Industry to 2027 – by Product, Application, End-use, Region and Segment Forecasts
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab

  Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab The European Medicines ...

author_avatar
NASDAQ Market News

Clearside Biomedical, Inc. Reports Second Quarter 2016 Financial Results

ALPHARETTA, Ga., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage ...

author_avatar
NASDAQ Market News

NeoTherma Oncology Raises $6 Million to Advance VectRx™ to Human Testing

WICHITA, Kan., Aug. 14, 2018 (GLOBE NEWSWIRE) -- NeoTherma Oncology (NTO), developer of an ...

author_avatar
NASDAQ Market News